Noticias de Eulerpool Oric Pharmaceuticals

Oric Pharmaceuticals Noticias de Acciones

Oric Pharmaceuticals es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Oric Pharmaceuticals.

• 13 de junio ·

  Yahoo
  What Makes Oric Pharmaceuticals, Inc. (ORIC) a Strong Momentum Stock: Buy Now?
• 13 de junio ·

  Yahoo
  JPMorgan biotech/pharma analysts hold analyst/industry conference call
• 29 de mayo ·

  Yahoo
  ORIC Pharmaceuticals, Inc. (ORIC) Secures $125M to Advance ORIC-944 Phase 3 Trials
• 28 de mayo ·

  Yahoo
  ORIC Reports Preliminary Efficacy in Metastatic Prostate Cancer Study; Starts $125 Million Private Placement
• 27 de mayo ·

  Yahoo
  ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC
• 22 de abril ·

  SeekingAlpha
  ORIC Pharmaceuticals: Multiple Data Releases In 2025 Make It A Must-Watch Biotech
• 22 de abril ·

  SeekingAlpha
  ORIC Pharmaceuticals: Looking To The Horizon With Pivotal Study Plans
• 16 de abril ·

  Yahoo
  Is ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) the Best Biotech Penny Stock to Buy According to Hedge Funds?
• 4 de abril ·

  Yahoo
  ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• 2 de febrero ·

  SeekingAlpha
  ORIC Pharmaceuticals: Too Early To Commit, Despite Some Good Early Data